Erratum to "Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS" [J. Neuroimmunol. 195 (2008)135-139] (DOI:10.1016/j.jneuroim.2008.01.016);Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS

Journal of Neuroimmunology

Volumn 195, Issue 1-2, 2008, Pages 135-139

  Vaknin Dembinsky, Adi ^a   Brass, Steven ^a   Gandhi, Roopali ^a   Weiner, Howard L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

IL 15; Monocytes; Multiple sclerosis

Indexed keywords

CD14 ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MEMBRANE BINDING; MONOCYTE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TH1 CELL;

EID: 41949095273     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.10.002     Document Type: Erratum

References (33)

1. Agostini C., Trentin L., Facco M., Sancetta R., Cerutti A., Tassinari C., Cimarosto L., Adami F., Cipriani A., Zambello R., and Semenzato G. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J. Immunol. 157 (1996) 910-918
2. Balashov K.E., Smith D.R., Khoury S.J., Hafler D.A., and Weiner H.L. Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 599-603
3. Baranda L., de la Fuente H., Layseca-Espinosa E., Portales-Perez D., Nino-Moreno P., Valencia-Pacheco G., Abud-Mendoza C., Alcocer-Varela J., and Gonzalez-Amaro R. IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus. Rheumatol. (Oxford) 44 (2005) 1507-1513
4. Baranzini S.E., Elfstrom C., Chang S.Y., Butunoi C., Murray R., Higuchi R., and Oksenberg J.R. Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression. J. Immunol. 165 (2000) 6576-6582
5. Bettelli E., Oukka M., and Kuchroo V.K. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8 (2007) 345-350
6. Bulfone-Paus S., Ungureanu D., Pohl T., Lindner G., Paus R., Ruckert R., Krause H., and Kunzendorf U. Interleukin-15 protects from lethal apoptosis in vivo. Nat. Med. 3 (1997) 1124-1128
7. Carson W.E., Ross M.E., Baiocchi R.A., Marien M.J., Boiani N., Grabstein K., and Caligiuri M.A. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J. Clin. Invest. 96 (1995) 2578-2582
8. Giri J.G., Ahdieh M., Eisenman J., Shanebeck K., Grabstein K., Kumaki S., Namen A., Park L.S., Cosman D., and Anderson D. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. Embo J. 13 (1994) 2822-2830
9. Giri J.G., Kumaki S., Ahdieh M., Friend D.J., Loomis A., Shanebeck K., DuBose R., Cosman D., Park L.S., and Anderson D.M. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. Embo J 14 (1995) 3654-3663
10. Gonzalez-Alvaro I., Dominguez-Jimenez C., Ortiz A.M., Nunez-Gonzalez V., Roda-Navarro P., Fernandez-Ruiz E., Sancho D., and Sanchez-Madrid F. Interleukin-15 and interferon-gamma participate in the cross-talk between natural killer and monocytic cells required for tumour necrosis factor production. Arthritis Res. Ther. 8 (2006) R88
11. Grabstein K.H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., Beers C., Richardson J., Schoenborn M.A., Ahdieh M., et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264 (1994) 965-968
12. Karni A., Abraham M., Monsonego A., Cai G., Freeman G.J., Hafler D., Khoury S.J., and Weiner H.L. Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response. J. Immunol. 177 (2006) 4196-4202
13. Karni A., Koldzic D.N., Bharanidharan P., Khoury S.J., and Weiner H.L. IL-18 is linked to raised IFN-gamma in multiple sclerosis and is induced by activated CD4(+) T cells via CD40-CD40 ligand interactions. J. Neuroimmunol. 125 (2002) 134-140
14. Kivisakk P., Matusevicius D., He B., Soderstrom M., Fredrikson S., and Link H. IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS). Clin. Exp. Immunol. 111 (1998) 193-197
15. Li X.C., Roy-Chaudhury P., Hancock W.W., Manfro R., Zand M.S., Li Y., Zheng X.X., Nickerson P.W., Steiger J., Malek T.R., and Strom T.B. IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection. J. Immunol. 161 (1998) 890-896
16. Link J., Soderstrom M., Olsson T., Hojeberg B., Ljungdahl A., and Link H. Increased transforming growth factor-beta, interleukin-4, and interferon-gamma in multiple sclerosis. Ann. Neurol. 36 (1994) 379-386
17. Liu Z., Geboes K., Colpaert S., D'Haens G.R., Rutgeerts P., and Ceuppens J.L. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. J. Immunol. 164 (2000) 3608-3615
18. Makhlouf K., Weiner H.L., and Khoury S.J. Increased percentage of IL-12 + monocytes in the blood correlates with the presence of active MRI lesions in MS. J. Neuroimmunol. 119 (2001) 145-149
19. McInnes I.B., al-Mughales J., Field M., Leung B.P., Huang F.P., Dixon R., Sturrock R.D., Wilkinson P.C., and Liew F.Y. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat. Med. 2 (1996) 175-182
20. Musso T., Calosso L., Zucca M., Millesimo M., Ravarino D., Giovarelli M., Malavasi F., Ponzi A.N., Paus R., and Bulfone-Paus S. Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood 93 (1999) 3531-3539
21. Nieto M., del Pozo M.A., and Sanchez-Madrid F. Interleukin-15 induces adhesion receptor redistribution in T lymphocytes. Eur. J. Immunol. 26 (1996) 1302-1307
22. Panitch H.S., Hirsch R.L., Haley A.S., and Johnson K.P. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1 (1987) 893-895
23. Pashenkov M., Mustafa M., Kivisakk P., and Link H. Levels of interleukin-15-expressing blood mononuclear cells are elevated in multiple sclerosis. Scand. J. Immunol. 50 (1999) 302-308
24. Rentzos M., Cambouri C., Rombos A., Nikolaou C., Anagnostouli M., Tsoutsou A., Dimitrakopoulos A., Triantafyllou N., and Vassilopoulos D. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis. J. Neurol. Sci. 241 (2006) 25-29
25. Ruchatz H., Leung B.P., Wei X.Q., McInnes I.B., and Liew F.Y. Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J. Immunol. 160 (1998) 5654-5660
26. Sospedra M., and Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23 (2005) 683-747
27. Tagaya Y., Bamford R.N., DeFilippis A.P., and Waldmann T.A. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 4 (1996) 329-336
28. Thurkow E.W., van der Heijden I.M., Breedveld F.C., Smeets T.J., Daha M.R., Kluin P.M., Meinders A.E., and Tak P.P. Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with Yersinia-induced arthritis and osteoarthritis. J. Pathol. 181 (1997) 444-450
29. Vaknin-Dembinsky A., Balashov K., and Weiner H.L. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J. Immunol. 176 (2006) 7768-7774
30. Van Belle T., and Grooten J. IL-15 and IL-15Ralpha in CD4+T cell immunity. Arch. Immunol. Ther. Exp. (Warsz) 53 (2005) 115-126
31. Waldmann T.A., and Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu. Rev. Immunol. 17 (1999) 19-49
32. Weiner H.L. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease. Arch. Neurol. 61 (2004) 1613-1615
33. Yoshihara K., Yamada H., Hori A., Yajima T., Kubo C., and Yoshikai Y. IL-15 exacerbates collagen-induced arthritis with an enhanced CD4+ T cell response to produce IL-17. Eur. J. Immunol. 37 (2007) 2744-2752